CPhI Worldwide records 44,500 attendees from 164 countries
CPhI Worldwide pharma survey shows improving outlook for pharma economies globally, with China and India showing the fastest…
Author
US FDA expands approval of Roche hemophilia drug
Roche is looking to capture a big share of a $ 10 billion-per-year hemophilia market from established rivals like Shire, Bayer AG…
Jiva Ayurveda, Gargi College, introduces six-month Ayurveda and Yoga course
The launch of the course in Gargi College is part of Jiva Ayurveda’s ongoing initiative to propagate the knowledge of Ayurveda…
Endothelial progenitor cells are safe for treating stroke patients, reveals study
Eighteen patients were recruited for the randomized, single-blinded study
Panacea Biotec inks Tripartite agreement with Natco Pharma, Breckenridge Pharmaceutical
As per the agreement the Panacea will manufacture and supply of Azacitidine injection in the US market
Lupin gets US FDA nod to market postherpetic neuralgia drug
The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths
Cadila gets five observations from US FDA
The inspection was conducted at its subsidiary Liva Pharmaceuticals' injectables manufacturing facility in Vadodara
Suven secures product patents in China, Eurasia
The granted claims of the patents are being developed as therapeutic agents useful in the treatment of cognitive impairment…
Glenmark to market Tiotropium Bromide dry powder inhaler in Western Europe
Tiotropium Bromide DPI is a generic version of Boehringer Ingelheim's Spiriva Handihaler
Novartis wins EU approval for blood cancer therapy Kymriah
Novartis is investing 90 million Swiss francs ($90.4 million) in a new Swiss facility to produce Kymriah